Patent · US Active

Use of inhibitors of the renin-angiotensin system

US8003679B2 · kind B2 · utility

0Cited by

23References

2Claims

0Family size

Assignee

Ark Therapeutics Group, plc · GB

Inventors

Hugh Edward Montgomery · London, GB
John Francis Martin · Danvers, US
Jorge Daniel Erusalimsky · London, GB

Key dates

Filing date	May 25, 2006
Grant date	Aug 23, 2011
Priority date	—
Expiry date	May 12, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC08G61/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Inhibitors of the rennin-angiotensin system are useful for the treatment or prevention of conditions associated with hypoxia, such as stroke.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.